Skip to content
Use caution Medical device recall · FDA · Published June 16, 2026

Medtronic MiniMed Go App Version 1.0.0/1.1.0 May Cause Missed Insulin Doses

Medtronic MiniMed recalls Go app versions 1.0.0 and 1.1.0 for iOS and Android devices. These versions may not trigger nighttime alerts when certain settings are disabled, risking missed insulin doses and hyperglycemia.

🇺🇸 FDA recall #Z-2778-2026Medical deviceMedtronic MiniMed ›
✎ GovInfoNow plain-language explainer

Medtronic MiniMed is recalling its Go app versions 1.0.0 and 1.1.0 for iOS and Android devices. If nighttime alerts are turned off while missed dose or high glucose alerts are enabled, the app won't trigger nighttime alerts, which could lead to missed insulin doses and hyperglycemia. Read more at govinfonow.com/recall/127770-medtronic-minimed-go-app-version-1-0-0-1-1.

Source Summary by GovInfoNow · govinfonow.com/recall/127770-medtronic-minimed-go-app-version-1-0-0-1-1 · Updated August 10, 2026 · FDA enforcement record: FDA #Z-2778-2026

Cite this page

“Medtronic MiniMed Go App Version 1.0.0/1.1.0 May Cause Missed Insulin Doses.” GovInfoNow, updated August 10, 2026. https://govinfonow.com/recall/127770-medtronic-minimed-go-app-version-1-0-0-1-1. Based on FDA recall #Z-2778-2026 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2778-2026%22&limit=1).

The FDA announced on June 16, 2026, that Medtronic MiniMed is recalling the MiniMed Go App (models MMT-8600 and MMT-8601) because nighttime alerts for missed doses or high glucose may fail to trigger. This defect could result in users missing rapid-acting insulin doses without knowing it.

How to tell if you have it

  • Brand: Medtronic MiniMed
  • Product: MiniMed Go App
  • Model: MMT-8600 (iOS), MMT-8601 (Android)
  • Software Versions: 1.0.0, 1.1.0
  • Model/UDI-DI: MMT-8600/00199150038978(10)1.1.0, MMT-8601/00199150038985(10)1.1.0
  • Distribution: US Nationwide (including PR, OH, WA, IL, NC, PA, VA, MN, ID, CA, UT, MI, NJ, MS, SC, CO, AZ, OR, AR, MO, TX, AL, FL, NY, IN, TN, IA, WI, MA, LA, OK, GA, KS, NM, CT, KY, NH, NV, MD) and Australia, Switzerland, Germany, Denmark, Spain, Finland, Iceland, Norway, Sweden
  • Units affected: 3,465

The hazard

According to the FDA, when the 'Set day and night' feature is turned off and 'missed dose' or 'Correct high glucose' alerts are enabled, the associated alerts will not trigger during the nighttime. This could result in missed rapid-acting insulin doses without the user's knowledge, potentially leading to delayed therapy and an increased risk of hyperglycemia.

Context

GovInfoNow's records show Medtronic MiniMed has issued 13 other recalls since November 15, 2023. Recent brand recalls include a July 13, 2026 recall of the Medtronic MiniMed 670G Insulin Pump for risk of incorrect insulin delivery and a May 27, 2026 recall of the Medtronic MiniMed 780G Insulin Pump due to software errors causing insulin stoppage. Other recent recalls of similar products include the Dexcom G7 CGM App recall from April 14, 2026 (risk of missing glucose alerts) and the Dexcom ONE+ App recall from April 14, 2026 (software defect may cause glucose readings to miss hypoglycemia).

How to tell if you have this one

Check your MiniMed Go app version by going to Settings > About. Affected versions are 1.0.0 and 1.1.0 for iOS (MMT-8600) and Android (MMT-8601) devices.

  • Brand
    Medtronic MiniMed
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check App Version

    Go to Settings > About in the MiniMed Go app to see the version number.

  2. Update App

    Update to the latest version of the MiniMed Go app to fix the alert issue.

Where it went and when

Where it was distributed

Distributed nationwide and abroad; the notice names 38 states.

Alaska: nationwideAKMaine: nationwideMEVermont: nationwideVTNew Hampshire: named in the noticeNHWashington: named in the noticeWAIdaho: named in the noticeIDMontana: nationwideMTNorth Dakota: nationwideNDMinnesota: named in the noticeMNIllinois: named in the noticeILWisconsin: named in the noticeWIMichigan: named in the noticeMINew York: named in the noticeNYRhode Island: nationwideRIMassachusetts: named in the noticeMAOregon: named in the noticeORNevada: named in the noticeNVWyoming: nationwideWYSouth Dakota: nationwideSDIowa: named in the noticeIAIndiana: named in the noticeINOhio: named in the noticeOHPennsylvania: named in the noticePANew Jersey: named in the noticeNJConnecticut: named in the noticeCTCalifornia: named in the noticeCAUtah: named in the noticeUTColorado: named in the noticeCONebraska: nationwideNEMissouri: named in the noticeMOKentucky: named in the noticeKYWest Virginia: nationwideWVVirginia: named in the noticeVAMaryland: named in the noticeMDDelaware: nationwideDEArizona: named in the noticeAZNew Mexico: named in the noticeNMKansas: named in the noticeKSArkansas: named in the noticeARTennessee: named in the noticeTNNorth Carolina: named in the noticeNCSouth Carolina: named in the noticeSCDistrict of Columbia: nationwideDCOklahoma: named in the noticeOKLouisiana: named in the noticeLAMississippi: named in the noticeMSAlabama: named in the noticeALGeorgia: named in the noticeGAHawaii: nationwideHITexas: named in the noticeTXFlorida: named in the noticeFLPuerto Rico: named in the noticePR

FDA distribution: “Worldwide - US Nationwide distribution in the states and territories of PR, OH, WA, IL, NC, PA, VA, MN, ID, CA, UT, MI, NJ, MS, SC, CO, AZ, OR, AR, MO, TX, AL, FL, NY, IN, TN, IA, WI, MA, LA, OK, GA, KS, NM, CT, KY, NH, NV, MD and the…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, South Carolina, Tennessee, Texas, Utah, Virginia, Washington, Wisconsin.

Recall timeline

FDA published this recall 43 days after the firm started it.

1. Firm started the recall: Jun 16, 202612. FDA classified it Class II: Jul 23, 202623. Published in FDA’s Enforcement Report: Jul 29, 202632026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Do I need to stop using the app immediately?

No, but you should update to the latest version to fix the issue. The recall does not require immediate discontinuation.

Similar recalls

Other Medtronic MiniMed recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-2778-2026 (June 16, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2778-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 10, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA